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Abstract
Background: Asthma is the most common cause of respiratory disorders among children. We aimed to investigate
left (LV) and right (RV) ventricular function in asthmatic children as detected by conventional and tissue Doppler
echocardiography.
Methods: Fifty pediatric patients with asthma and forty healthy children were studied. Pulmonary function tests,
electrocardiography and echocardiographic examinations were performed on all children.
Results: Rate-corrected velocity of circumferential fiber shortening (VCFc) (p = 0.044), the ratio between heights of
early and late diastolic flow velocity peaks (E/A) (p = 0.019) and LV end-systolic wall stress (ESWSm) was lower (p = 0.
003), RV stroke volume (SV) (p = 0.002), LV SV (p = 0.001), tricuspid annular plane systolic excursion (TAPSE) (p = 0.034),
tricuspid annular peak velocity during systole (S’) (p = 0.022), tricuspid and mitral early diastolic velocities (E’) (p = 0.012,
p = 0.003 respectively) were lower in asthmatic children than controls. The mitral valve ejection time (ET) was high in
asthmatic group (p = 0.027).
FEV1 was positively correlated with isovolumetric relaxation time (IVRT) (p = 0.018) (r = 0.382) and mitral ET (p = 0.
018) (r = 0.381). PEF was negatively correlated with the RV work index (p = 0.032) (r = -0.348) and LV work index (p = 0.
005) (r = -0.457).
Conclusion: Although cardiac systolic function was found to be impaired in asthmatic patients, contrary to the
literature, diastolic dysfunction was not observed in these patients, even by tissue Doppler imaging, and this finding
may be attributed to using inhaled corticosteroid
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Background
Asthma is a chronic inflammatory disease of the air-
ways which is related to airway obstruction, hyper-
responsiveness and characterized recurrent wheezing,
coughing and breathlessness [1]. Bronchial asthma af-
fects many organs including the heart. There are many
explanations for the occurrence of cardiac dysfunction
in asthmatic children [2–4]. It is suggested that chronic
hypoxia may cause pulmonary arterial hypertension,
which causes RV hypertrophy and/or dilatation [2]. It is
also suggested that recurrent hypoxemia and the release
of various mediators and cytokines in bronchial asthma
may cause chronic inflammation, which could induce
pulmonary vasoconstriction [3, 4]. Other hypotheses
concluded that the exaggerated respiratory efforts may
raise intrathoracic pressure that increases RV afterload
and consequently pulmonary hypertension with RV
hypertrophy and/or dilatation. As a result, pulmonary
hypertension occurs and leads to RV hypertrophy and/
or dilatation [3–5]. As a result of chronic pressure
overload, the RV hypertrophies and dilates and leads to
both systolic and diastolic dysfunction [5]. The level of
RV diastolic dysfunction depends on the degree of RV
hypertrophy and total pulmonary resistance. Interaction
between the RV and LV related to increased LV afterload
and decreased LV preload, and thus LV dysfunction [6].
There are important limitations to determining RV
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function by conventional echocardiography [7]. The
unavailability of the RV at the back the sternum leads to
poor image quality. Also, locating the endocardial bound-
ary of the anterior wall is a problem owing to the thicker
trabeculations compared with the LV. Furthermore, the
RV cavity has a more complex geometry than the LV, and
RV performance depends on extrinsic conditions, such as
afterload, preload, and LV performance.
Our study aimed to investigate ventricular diastolic and
systolic functions, LV wall stresses and circumferential
fiber shortening by using tissue Doppler imaging (TDI)
and conventional echocardiography in asthmatic children,
using regular inhaled corticosteroid, without any cardio-
vascular symptoms.
Methods
We studied 50 pediatric patients (35 male and 15 female),
selected randomly from those with bronchial asthma, and
40 healthy subjects. Inclusion criteria include all patients
meeting the criteria for bronchial asthma [1]. Exclusion
criteria were patients with comorbid diseases, such as
upper or lower respiratory infection, allergic rhinitis, gas-
troesophageal reflux, obesity, chronic cardiovascular or
pulmonary diseases and acute asthma attack during the
last 4 weeks.
The control group was chosen from healthy individuals.
The ethics committee of the institution approved the
study and informed consent forms signed by the parents
were obtained. All the children included in the study were
subjected to full history taking. Complete physical exami-
nations were performed by the same physician. Body
height and weight, blood pressure (BP) and heart rate of
all children were recorded. The patients and the controls
who were >6 years underwent pulmonary function tests
using spirometry forced expiratory volume in 1 s (FEV1),
forced vital capacity (FVC), the ratio of FEV1 to FVC, and
peak expiratory flow (PEF), which were all documented.
All asthmatic patients involved in this study were mod-
erately asthmatic and received inhaled corticosteroid
treatment for different periods of time and doses.
An electrocardiogram was simultaneously recorded
for all patients. Transthoracic echocardiography was
performed by a single experienced pediatric cardiolo-
gist, blinded to the subjects, and the following parame-
ters were monitored: LV end-diastolic pressures
(LVEDPs), LV mass (LVM, g) according to the formula
of Devereux [8], stroke volume (SV), ejection fraction
(EF, %), fractional shortening (FS, %), ratio between
heights of early and late diastolic flow velocity peaks
(E/A ratio) for both mitral and tricuspid valves, deceler-
ation time (DT, ms), LV meridional end-systolic wall
stress (ESWSm, g/cm2), Midwall Shortening Fraction
(SFmid), heart rate corrected circumferential fiber
shortening (VCFc), midwall VCFc, myocardial fiber
stress (MFS, g/cm2), RV and LV work index (RVWI,
LVWI respectively), LV and RV relative wall thickness
(LVRWT, RVRWT, mm) mitral and tricuspid annular
plane systolic excursion (MAPSE, TAPSE), RV Pre-
ejection Period/RV ejection time (RVPEP/RVET), RV
Pre-ejection period/RV acceleration time (RPEP/AT),
and Acceleration time/Pulmonary artery ejection time
(AT/PAET).
The following parameters were monitored by TDI:
annular peak velocity during late diastole (A’) annular
peak velocity during early diastole (E’), isovolumetric
relaxation time (IVRT), isovolumetric contraction time
(IVCT), myocardial performance index (MPI), annular
peak velocity during systole (S’), ejection time (ET),
time velocity integral for aortic valve (Aort VTI), time
velocity integral for pulmonary artery (PA VTI), mitral
valve myocardial acceleration during isovolumic
contraction (IVMA-MV), tricuspid valve myocardial ac-
celeration during isovolumic contraction (IVMA-TV),
and pulmonary artery myocardial acceleration during
isovolumic contraction (IVMA-PA).
EF, SV, LVOT and AoVTI were calculated as described
in previous studies [9].
LV fractional shortening (FS) was calculated as LVVD-
LVDS/LVDD [10].
Mitral and tricuspid filling velocities were recorded
from the apical four-chamber view with the pulse-wave
Doppler during diastole. E/A and DT were used as both
ventricular diastolic function parameters. The ratios of E
to A were calculated for mitral and tricuspid valves [11].
The Doppler-derived myocardial performance index
(MPI) for LV and RV, combining systolic and diastolic
time intervals, were calculated IVCT+ IVRT/ET [12].
VCFc (circ/s) = (SF x (1500/heart rate)0.5/LV ET)
Midwall VCFc was calculated as = 0.0007xMFS + 0.65
ESWSm was calculated by the method of Grossman et
al [12] and MFS according to the formula recommended
by Regen [13].
SFmid = [(LVED + hd/2 + sd/2) – LVES – mwst]/(LVED+
hd/2 + sd/2)
Where the mwst calculared as = [(LVED + (hd + sd)/2)
3 -
LVED3 + LVES3)0,333 –LVES]
hd : left ventricular end-diastolic posterior wall
thickness
sd: end-diastolic septal thickness
LVES stands for LV end systolic dimension and LVED
stands for LV end diastolic dimension.
LVEDP = 21.6 (Q-M1/A2-OS) + 1.1, OS: opening snap
of the mitral valve, A2: aortic component of the second
heart sound, Q: Q wave on the ECG, M1: mitral compo-
nent of the first heart sound [14].
RV and LV function were also evaluated using TDI:
Peak systolic (S’) and early and late diastolic velocities
(E’ and A’) were measured from the apical four-chamber
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view with the pulsed-wave Doppler sample volume
placed at the tricuspid and mitral annulus.
Cardiac time intervals comprising RV included IVCT
from the end of the tricuspid flow to the beginning of the
pulmonary flow, IVRT from the end of the pulmonary
flow to the beginning of the tricuspid flow, and ET from
the beginning to the end of the pulmonary flow were also
measured.
Statistical analysis
The statistical analyses were performed by the Statistical
Package for Social Sciences (SPSS). Kolmogorov–Smirnov
and Shapiro Wilk tests were used to assess normality of
distribution.
Parametric variables were compared using the Student’s t
test for normally distributed data and the Mann Whitney u
test for not normally distributed data. Bivariate associations
of the variables were assessed using Pearson’s correlation
coefficients. Variables were expressed as mean ± SD
and p value <0.05 was considered to indicate statis-
tical significance.
Results
The current study enrolled 50 patients (35 boys and 15
girls) with a mean age of 10.56 ± 3.03 years who had
diagnosis of bronchial asthma. The characteristics of the
children and healthy subjects are shown in Table 1. The
spirometry findings are summarized in Table 2.
LV and RV echocardiographic findings are listed in
Tables 3 and 4. The rate-corrected velocity of circumfer-
ential fiber shortening (VCFc) (p = 0.044), E/A ratio (p =
0.019), ESWSm was lower (p = 0.003), RSV (p = 0.002),
LSV (p = 0.001), tricuspid annular peak velocity during
systole (S’) (p = 0.022), TAPSE (p = 0.034) and tricuspid
and mitral E’ (p = 0.012, p = 0.003 respectively) were
lower in asthmatic children than control subjects. Mitral
valve ET was higher in the asthmatic group (p = 0.027).
Distribution of ESWSm between groups is showed in
Fig. 1. TDI parameters are listed in Table 5.
We performed pulmonary function tests on patient and
control groups and correlated FEV1, FVC, FEV1/FVC and
PEF with cardiac parameters. There were no differences be-
tween the asthmatic and control group. In correlation ana-
lysis, FEV1 was positively correlated with IVRT (p = 0.018)
(r = 0.382) and ET-MV (p = 0.018) (r = 0.381). PEF was
negatively correlated with RVWI (p = 0.032), (r = -0.348)
and LVWI (p = 0.005), (r = -0.457).
Discussion
Asthma is the most common cause of respiratory disability
in children [3]. We aimed to investigate both ventricular
Table 1 Comparison (mean ± SD) of clinical characteristics
Variable asthmatic children Healthy control p
valuen = 50 n = 40
Age (years) 10.56 ± 3.03 12.08 ± 3.21 0.250a
Male/female 35/15 17/23 0.314c
Body height (cm) 142.8 ± 12.2 144.5 ± 12.4 0.120b
Body weight (kg) 28.6 ± 12.5 28.6 ± 12.5 0.480b
Heart rate (bpm) 84.68 ± 14.93 86.42 ± 10.87 0.537a
Systolic BP (mmHg) 104.74 ± 8.94 103.78 ± 9.47 0.345b
Diastolic BP (mmHg) 64.02 ± 5.88 61.38 ± 9.63 0.175b
a Student’s t test, b Man-Whitney u test, c Chi-square test
Table 2 Comparison (mean ± SD) of spirometry findings
Variable asthmatic children Healthy controls p
valuean = 50 n = 40
PEF 90.02 ± 9.7 92.7 ± 8.9 0.320
FEV1 82.8 ± 12.2 92.2 ± 9.3 0.002*
FVC 92.1 ± 8.5 95.2 ± 11.4 0.123
FEV1/FVC 89.6 ± 9.7 96.2 ± 10.5 0.012*
a Student’s t test
*Correlation is significant at the 0.05 level
Table 3 Comparison (mean ± SD) of left ventricular
echocardiographic findings
Variable Asthmatic children Healthy controls p
value50 (M/F = 35/15) 40 (M/F = 17/23)
LSV (ml) 40.75 ± 14.26 50.99 ± 13.08 0.001a
LVWT (cm) 0,40 ± 0,087 0,38 ± 0,055 0,172a
LV-EF (%) 0.66 ± 0.1 0.63 ± 0.07 0.182a
DT (msn) 184.79 ± 53.98 192.50 ± 45.60 0.465a
LV-FS (%) 0.36 ± 0.08 0.34 ± 0.05 0.185a
LVM (gr) 67.03 ± 22.89 69 ± 18.26 0.440b
E/A 1.78 ± 0.27 1.93 ± 0.32 0.019a
L-sist (ms) 340.34 ± 42.89 346.83 ± 28.01 0.485b
MAPSE (cm) 1.09 ± 0.18 1.07 ± 0.17 0.672b
LVEDP (mmHg) 26.45 ± 5.11 26.96 ± 4.63 0.451b
LVWI (gm-m/m2) 35.61 ± 9.41 33.32 ± 7.24 0.387b
WSM (g/cm2) 1114.18 ± 595.42 1356.16 ± 562.54 0.053a
ESWSm (g/cm2) 172.5 ± 58.05 209.22 ± 55.53 0.003a
VCFc (circ/s) 0.0051005 ± 0.00 0,0057375 ± 0.00 0.044b
Sfmid (%) -0.36 ± 0.10 -0.38 ± 0.07 0.257b
Fiber stress (g/cm2) 36.55 ± 9.32 39.74 ± 11.61 0.160b
Midwall VCFc (circ/s) 0.67 ± 0.01 0.68 ± 0.01 0.160b
LSV Left ventricle stroke volume, LVWT Left ventricular wall thickness, EF
Ejection fraction, DT Deceleration time, LV_FS Left ventricle fractional
shortening, LVM Left ventricular mass, A Peak velocity during late diastole, E
Peak velocity during early diastole, L-sist T Left Systolic Time (Contraction
time), MAPSE Mitral annular plane systolic excursion; LVEDP Left Ventricle
end-diastolic Pressure, LVWI Left ventricular work index; WSM Meridional LV
wall stress, ESWSm Meridional end-systolic wall stress, VCFc Rate-corrected
velocity of circumferential fiber shortening
a Student’s t test, b Mann-Whitney u test
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function in children with bronchial asthma as detected by
conventional echocardiography and TDI.
Our results confirms the results reported by She-
deed et al [15] and Mahmoud et al [16] who found no
statistically significant differences between asthmatic
children and controls regarding heart rate and systolic
and diastolic BP.
According to some studies right ventricular (RV) sys-
tolic and diastolic dysfunction were detected, even in
mild cases, by echocardiography. On the other hand, left
ventricular (LV) dysfunction usually presents itself in
severe asthmatic cases which may be reversible in acute
conditions [17, 18].
Some studies showed that there were no differences
in echocardiographic findings regarding the ventricu-
lar function with the exception of RV wall thickness
[15, 19]. We couldn’t find any differences between the
two groups regarding RVWT and LVWT.
IVMA, MPI, EF, FS, TAPSE, MAPSE, SV, VCFc and
ESWSm values of both ventricles were evaluated to as-
sess ventricular systolic function. IVMA, MPI, EF, FS
and MAPSE were similar in both groups. TAPSE was
lower in asthmatic patients.
IVMA is a measurement of ventricular contractile
function that is unaffected by preload and afterload
changes in a physiological range [20]. In this study we
couldn’t show any differences between IVMA values in
either group.
The SV of both the RV and LV were lower in asthmatic
children than in the controls in our study. Hedlin et al
Table 4 Comparison (mean ± SD) of right ventricular
echocardiographic findings
Variable asthmatic children Healthy controls p
value50 (M/F = 35/15) 40 (M/F = 17/23)
RSV (ml) 50.01 ± 18.26 64.70 ± 23.66 0.002b
RVWT (cm) 0,47 ± 0,11 0,47 ± 0,10 0.980a
RV-EF (%) 0.73 ± 0.15 0.71 ± 0.13 0.385b
DT (msn) 198.19 ± 62.73 189.87 ± 46.76 0.490b
RV-FS (%) 0.42 ± 0.12 0.39 ± 0.10 0.372a
E/A 1.72 ± 0.26 1.80 ± 0.33 0.243a
R-sist (ms) 362.78 ± 32.74 362.72 ± 28.90 0.807b
TAPSE (cm) 2.02 ± 0.20 2.15 ± 0.32 0.034b
RV WI (gm-m/m2) 4.24 ± 1.20 4.57 ± 1.68 0.572b
RVPEP/RVET (ms) 0.19 ± 0.04 0.19 ± 0.03 0.767b
RPEP/AT (ms) 0.50 ± 0.13 0.51 ± 0.11 0.679b
AT/PAET (ms) 0.39 ± 0.06 0.38 ± 0.05 0.372b
RSV Right ventricle stroke volume, RVWT Right ventricular wall thickness, RV-EF
Right ventricle ejection fraction; RV-FS Right ventricle fractional shortening, A
Peak velocity during late diastole, E Peak velocity during early diastole, DT
Deceleration Time, R-sist T Right ventricle systolic time (contraction time),
TAPSE Tricuspid annular plane systolic excursion, RVWI Right ventricular work
index, RVPEP/RVET Right Ventricle Pre-Ejection Period/Right ventricle Ejection
Time, RPEP/AT Right ventricle Pre-Ejection Period/Right ventricle Acceleration
Time, AT/PAET Acceleration time/Pulmonary artery Ejection Time
a student’s t test, b Mann-Whitney u test
Fig. 1 Distribution of LV meridional end-systolic wall stress (ESWSm) between groups
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[21] reported that SV decreased in asthmatic patients
whose asthma was provoked by exercise and increased
with inhale salbutamol.
To assess LV contractility, we also analyzed changes in
LV VCFc and afterload (ESWSm) [12]. The ventricular
contractility and myocardial performance may have been
affected by chamber geometry, which need to be identi-
fied by measuring ESWSm, VCFc-midwall and MFS.
ESWSm was accepted as afterload (no more shortening
point). ESWSm, which is dependent on both chamber
shape and mass/volume ratio, demonstrates the forces
opposing predominantly meridional and circumferential
planes. This is an index of total forces per unit of myo-
cardium, and therefore may cause an underestimation in
true afterload. MFS, as representative of myofiber after-
load, is a more accurate index of afterload in hypertro-
phied or dilated LV [22]. In the current study, ESWSm
and VCFc were low, while MFS was similar in the asth-
matic group. SFmid as a systolic ejection index of deeper
layers of myocardium provides more physiologically ap-
propriate measurements of LV in wall thickness and
conditions like LV concentric hypertrophy and provides
information to assess the myocardial performance [22].
In this study, SFmid was similar in both groups. As an
indication of compromised LV contractility, LV ESWSm
was significantly lower in asthmatic patients.
To evaluate ventricular diastolic function we used
mitral and tricuspid E/A, E’, A’, DT, IVRT and IVCT by
using conventional echocardiography and TDI. There
are some studies which reported RV and LV diastolic
dysfunction in patients with moderate to severe asthma
[2, 23, 24]. In contrast with these studies, we turned
away from the diagnosis of diastolic dysfunction in asth-
matic patients because both mitral and tricuspid E/A
values were >1 without any sign of pseudo-normal E/A
values.
Mitral and tricuspid annulus early diastolic velocities
were different by TDI. Mitral E’, tricuspid E’ and S’ were
lower in the asthmatic group. There were no significant
differences among the IVCT, IVRT and DT in either the
mitral or tricuspid annulus. These findings showed that
there was no diastolic dysfunction among our asthmatic
children even by TDI. This result may due to use of
inhaled corticosteroids. Shedeed [15] reported that E’, A’,
and S’ were significantly lower, and E’/A’, IVRT, and
IVCT significantly greater in asthmatic children as
detected by TDI. Zeybek et al [18] showed that lateral
annular velocities of tricuspid and IVRT were different
between asthmatic children and controls. Abdalla et al
[25] suggested that LV diastolic function is impaired in
patients with bronchial asthma despite there being no
effect on RV diastolic function. Ozdemir et al [19]
revealed the same, although there was no difference by
conventional echocardiography in asthmatic children.
TDI showed subclinical dysfunction of the right ventricle
and they suggested that TDI was useful in the early
detection of some detrimental effects of asthmatic cases.
Hirschfeld et al [26] measured the RPEP and RVET in
64 pediatric patients undergoing cardiac catheterization
and demonstrated a strong correlation between pulmon-
ary artery diastolic pressure and the ratio RPEP/RVET
(r = 0.72). In one study it has been suggested that normal
RPEP/RVET was not significantly influenced by age or
heart rate, and therefore could be used as an index of
RV performance throughout a wide range of pediatric
age groups. On the other hand, the same study revealed
that the RPEP/RVET ratio correlated with mean pul-
monary artery pressure and was associated with pulmon-
ary vascular resistance [27]. The current study failed to
demonstrate any differences regarding the RVPEP/RVET
ratio between the groups.
Table 5 TDI findings (mean ± SD) of the patients and control
group
Variable asthmatic children Healthy controls p
value50 (M/F = 35/15) 40 (M/F = 17/23)
Mitral annulus
E’(m/sn) 0.17 ± 0.03 0.19 ± 0.03 0.003a
A’(m/sn) 0.08 ± 0.02 0.12 ± 0.21 0.635b
S’(m/sn) 0.072 ± 0.022 0.077 ± 0.013 0.147a
Aort-VTI (cm) 21.96 ± 3.91 22.48 ± 3.60 0.514a
IVCT (ms) 65.89 ± 11.57 69.05 ± 15.08 0.533a
IVRT (ms) 64.13 ± 8.87 64.05 ± 8.48 0.880b
ET-MV (ms) 265.53 ± 40.58 245.80 ± 30.90 0.027b
IVMA-MV (m/s2) 0.07 ± 0.03 0.08 ± 0.04 0.575b
Mitral-MPI (ms) 0.50 ± 0.09 0.54 ± 0.10 0.089b
Tricuspid annulus
E’ (m/sn) 0.17 ± 0.02 0.18 ± 0.02 0.012b
A’(m/sn) 0.11 ± 0.04 0.12 ± 0.03 0.968b
S’(m/sn) 0,08 ± 0,022 0,10 ± 0,028 0.022a
PA-VTI (cm) 21.87 ± 2.73 22.39 ± 2.80 0.377a
IVCT (ms) 66.63 ± 10.87 66.40 ± 13.07 0.517b
IVRT (ms) 65.74 ± 9.77 64.35 ± 8.26 0.436b
ET-TV (ms) 253.79 ± 36.58 241.10 ± 30.01 0.118b
IVMA-TV(m/s2) 0.09 ± 0.04 0.08 ± 0.04 0.955b
IVMA-PA(m/s2) 0.10 ± 0.17 0.08 ± 0.031 0.557a
Tricuspit MPI (ms) 0.53 ± 0.08 0.56 ± 0.09 0.070a
A’ Annular peak velocity during late diastole, E’ Annular peak velocity during
early diastole; IVRT Izovolumetric relaxation time, IVCT Izovolumetric
contraction time, MPI Myocardial performance index, S’ Annular peak velocity
during systole, ET Ejection time, Aort VTI Time velocity integral for aortic valve,
PA VTI Time velocity integral for pulmonary artery, IVMA-MV Mitral valve
myocardial acceleration during izovolumetric contraction, IVMA-TV Tricuspid
valve myocardial acceleration during izovolumetric contraction, IVMA-PA
Pulmonery artery myocardial acceleration during izovolumetric contraction
a student’s t test, b Mann-Whitney u test
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We performed pulmonary function tests in both
groups. FEV1 was positively correlated with IVRT and
ET-MV. PEF was negatively correlated with RVWI and
LVWI. Ozdemir et al [19] reported that PEF was nega-
tively correlated with tricuspid E’/A’, while Sheeded et al
[15] demonstrated a negative correlation between PEF
and IVRT.
Inhaled corticosteroids exert a strong anti-inflammatory
effect on airways; they represent the most effective agents
for long-term asthma control [28]. Some studies showed
that inhaled corticosteroids have protective effects on car-
diac function in asthmatic patients [29]. In the current
study, all the children were using inhaled corticosteroids
with a different period of time and doses and this study
showed that, even with this protective effect, myocardial
function can be impaired in asthmatic children.
In our previous study on asthmatic children who use
inhaled corticosteroid, arterial stiffness were decreased,
distensibility and strain were increased [30]. We sug-
gested that using inhaled corticosteroids could have pro-
vided certain protective effects in asthmatic children. A
proposed mechanism that may explain the decrease in
arterial stiffness involves nitric oxide synthesis and vaso-
dilatation [31].
Conclusion
Asthma affects ventricular contractility in children. Al-
though cardiac systolic function was found to be impaired
in asthmatic patients, contrary to the literature diastolic
dysfunction didn’t observed in these patients even by
tissue Doppler imaging, may be due to using inhaled
corticosteroid. This was one of the most comprehensive
studies among asthmatic patients. Further studies with
larger sample sizes or without using corticosteroid treat-
ment warranted to better elucidate the cardiac function in
asthmatic children.
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